Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,109 | 122 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $333.62 | 24 | $0 (2024) |
| ABBVIE INC. | $307.18 | 19 | $0 (2024) |
| Lilly USA, LLC | $292.01 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $197.13 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $158.52 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $155.39 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $109.88 | 7 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $95.01 | 4 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.89 | 5 | $0 (2023) |
| Amgen Inc. | $68.96 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.66 | 22 | Novo Nordisk Inc ($70.48) |
| 2023 | $608.98 | 36 | Lilly USA, LLC ($159.45) |
| 2022 | $848.54 | 50 | Novo Nordisk Inc ($192.78) |
| 2021 | $197.19 | 14 | Novo Nordisk Inc ($55.56) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $40.15 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Obesity | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: RESPIRATORY | ||||||
| 04/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Endocrinology | ||||||
| 04/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Obesity | ||||||
| 02/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neuroscience | ||||||
| 02/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Inflammation | ||||||
| 01/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $37.16 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/12/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 364 | 512 | $143,641 | $34,268 |
| 2022 | 17 | 370 | 527 | $120,215 | $36,678 |
| 2021 | 3 | 46 | 73 | $14,315 | $4,621 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 150 | $54,518 | $11,500 | 21.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 45 | $19,215 | $5,811 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 43 | $11,911 | $3,598 | 30.2% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 19 | 20 | $11,380 | $2,934 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $13,468 | $2,177 | 16.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 24 | $6,192 | $2,175 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $9,342 | $2,142 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 36 | $9,252 | $1,887 | 20.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $3,477 | $1,017 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 53 | $1,590 | $445.20 | 28.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 37 | $2,016 | $352.24 | 17.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 16 | $960.00 | $156.15 | 16.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 23 | $320.00 | $73.83 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 131 | $32,520 | $10,870 | 33.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 31 | 33 | $13,827 | $4,477 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 53 | $9,699 | $2,877 | 29.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 21 | 23 | $6,647 | $2,306 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $12,877 | $2,241 | 17.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 37 | 39 | $7,371 | $2,013 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 25 | $6,450 | $1,934 | 30.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,124 | $1,817 | 35.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 19 | 20 | $5,540 | $1,592 | 28.7% |
| 99235 | Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes | Facility | 2022 | 11 | 11 | $4,906 | $1,383 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 24 | $4,077 | $1,356 | 33.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 15 | 26 | $3,484 | $1,353 | 38.8% |
About Anna Spelts
Anna Spelts is a Internal Medicine healthcare provider based in Richmond Hill, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679090856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Spelts has received a total of $2,109 in payments from pharmaceutical and medical device companies, with $454.66 received in 2024. These payments were reported across 122 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,109).
As a Medicare-enrolled provider, Spelts has provided services to 780 Medicare beneficiaries, totaling 1,112 services with total Medicare billing of $75,566. Data is available for 3 years (2021–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Richmond Hill, GA
- Active Since 08/28/2017
- Last Updated 09/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679090856
Products in Payments
- VRAYLAR (Drug) $269.74
- TRELEGY ELLIPTA (Drug) $197.13
- Ozempic (Drug) $168.90
- MOUNJARO (Drug) $116.88
- Rybelsus (Drug) $115.53
- ENTRESTO (Drug) $109.88
- NURTEC ODT (Drug) $95.01
- SPRAVATO (Drug) $94.17
- JARDIANCE (Drug) $94.01
- TRULICITY (Drug) $75.38
- REXULTI (Drug) $65.53
- XARELTO (Drug) $64.35
- Otezla (Drug) $55.15
- BREZTRI (Drug) $52.91
- FARXIGA (Drug) $50.98
- ZEPBOUND (Drug) $42.33
- INSPIRE (Device) $40.15
- NEXLETOL (Drug) $33.78
- Dexcom G6 Transmitter (Medical Supply) $32.22
- AIRSUPRA (Drug) $31.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond Hill
Thomas Garner, M.d, M.D
Internal Medicine — Payments: $14,933
Dr. Douglas Perry, M.d, M.D
Internal Medicine — Payments: $10,239
Mrs. Rana Suleman, M.d, M.D
Internal Medicine — Payments: $7,998
Dr. Edward Hoffman, M.d, M.D
Internal Medicine — Payments: $6,744
Rita Jhaveri, Md, MD
Internal Medicine — Payments: $6,453
Dr. Wallace Holland, M.d, M.D
Internal Medicine — Payments: $3,068